Highlighting the GTM success post Series A investment
Burlington, Ontario | April 10, 2021 –
Tim Matthews, Interim CEO of AceAge Inc., has confirmed to present at the Bloom Burton & Co. Healthcare Investor Conference on April 20th, 2021 at 10:30am.
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings. This year’s conference will take place virtually. Please register here.
AceAge Inc., has developed and commercialized the Karie™ in-home smart pill companion that organizes, schedules, and delivers medication. The easy-to-use system adapts to patient’s routines, reminding them with visual and sound prompts to when it is time to take their medication. The Karie™ app allows caregivers to be notified if the patient misses doses, supporting timely interventions and promoting medication adherence.
“We will highlight how we are executing upon the key opportunities for growth in helping solve medication adherence challenges with both distribution and consumer based sales models” stated Tim Matthews, Interim CEO of AceAge Inc.
Since 2020, AceAge Inc. closed a CA $5 million Series A financing round and $1.5 million in FedDev Ontario repayable contribution, supporting their aggressive global growth strategy.
About AceAge Inc.
AceAge, a healthcare technology company creating intuitive products to ease the aging process and improve health outcomes. AceAge’s product, Karie, is a smart pill companion that organizes, schedules, and delivers pills, ideally suited for those needing to manage 3 or more medications simultaneously. Karie was designed to make medication management as simple as possible to ensure user independence and wellness, while providing caregivers with peace of mind.
About Bloom Burton & Co.
Bloom Burton & Co. (Bloom Burton Securities Inc.) is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).